NCT07046689View on ClinicalTrials.gov

PET/CT for Trop2 ADC Response Evaluation Cancers

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Breast CancerTrop2PET/CT
Interventions
DIAGNOSTIC_TEST

68Ga-MY6349 PET/CT

Each participant will receive an intravenous injection of 68Ga-MY6349 and undergo PET/CT imaging at baseline and following two cycles of Trop2-ADC therapy.

Trial Locations (1)

361000

RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER